Yuan, William
Beaulieu-Jones, Brett
Krolewski, Richard
Palmer, Nathan
Veyrat-Follet, Christine
Frau, Francesca
Cohen, Caroline
Bozzi, Sylvie
Cogswell, Meaghan
Kumar, Dinesh
Coulouvrat, Catherine
Leroy, Bruno
Fischer, Tanya Z.
Sardi, S. Pablo
Chandross, Karen J.
Rubin, Lee L.
Wills, Anne-Marie
Kohane, Isaac
Lipnick, Scott L.
Funding for this research was provided by:
Sanofi Aventis
U.S. National Library of Medicine (T15LM007092)
NVIDIA Graduate Fellowship
National Institute of Neurological Disorders and Stroke (K99NS114850)
Article History
Received: 22 August 2020
Accepted: 6 May 2021
First Online: 18 May 2021
Declarations
:
: Ethics approval and consent to participate has granted for all aspects of the study. For the administrative claims data, the Harvard Medical School Institutional Review Board approved the research using regularly collected deidentified data by waiving the requirement for patient consent for analysis of this database as it was deemed to not be human subjects research. The use of identifiable data from the Partners Healthcare system was approved under by the Institutional Review Board (Protocol #: 2017P002452).
: Not applicable.
: CVF, FF, CC, SB, MC, DK, CC, BL, TF, SPS, and KJC are Sanofi employees.